目的:双膝关节置换术中随机选择一侧置换髌骨,对侧保留髌骨,对比研究髌骨置换与否对术后临床效果的影响。方法:共入选14例双膝骨关节炎患者,28个膝,均为女性,年龄为53~78岁,平均(66.9±7.8)岁,体重指数为(26.3±1.8)kg/m2。随...目的:双膝关节置换术中随机选择一侧置换髌骨,对侧保留髌骨,对比研究髌骨置换与否对术后临床效果的影响。方法:共入选14例双膝骨关节炎患者,28个膝,均为女性,年龄为53~78岁,平均(66.9±7.8)岁,体重指数为(26.3±1.8)kg/m2。随机分组为拟行左侧或右侧髌骨置换和对侧髌骨保留,术后均获随访,随访时间为3~12个月。随访时记录患者手术前后双膝美国膝关节协会评分(American Knee Society score,KSS)、关节活动度(range of motion,ROM)、术后髌骨倾斜角(patellar tilt angle,PTA)、有无术后膝前痛及髌骨弹响、有无术后膝关节并发症等。结果:术后切口均一期愈合,无感染、松动、髌骨骨折等并发症发生。髌骨置换侧KSS评分由术前的(38.9±22.2)分提高至(92.4±6.7)分,术后较术前KSS增加值为(53.5±20.3)分;保留髌骨侧KSS评分由术前的(38.4±20.5)分提高至(92.1±4.2)分,术后较术前KSS增加为(53.7±21.4)分,两组间KSS评分的增加差异无统计学意义(P=0.98)。髌骨置换侧关节活动度由术前的95.4°±13.5°提高至120.4°±8.9°,术后ROM较术前增加为25.0°±14.5°;保留髌骨侧ROM由术前的92.9°±19.1°增加至120.4°±8.4°,术后较术前ROM增加为27.5°±19.4°,两组间ROM的增加差异也无统计学意义(P=0.70)。术后随访时,患者髌骨置换侧出现膝前痛共3膝(占21.4%),而保留髌骨侧膝前痛共出现2膝(占14.3%),两组间膝前痛的发生率比较差异无统计学意义(P=0.62)。术后髌骨置换侧出现髌骨弹响共3膝(占21.4%),保留髌骨侧3膝(占21.4%),组间比较差异无统计学意义。髌骨置换侧术后PTA为2.6°±2.6°,保留髌骨侧为3.6°±2.9°,两者间差异无统计学意义(P=0.36)。结论:全膝关节置换术中,对于髌骨关节面轻中度破坏的骨关节炎患者,髌骨置换较髌骨保留在术后膝前痛、髌骨弹响的发生率、术后关节功能改善及髌股轨迹等方面并无明显优势。展开更多
Chemokine-like factor 1（CKLF1） is a newly cloned chemotactic cytokine with CCR4 being its functional receptor. Recent evidence demonstrates a role of CKLF1 in arthritis. The aim of this study was to quantify the exp...Chemokine-like factor 1（CKLF1） is a newly cloned chemotactic cytokine with CCR4 being its functional receptor. Recent evidence demonstrates a role of CKLF1 in arthritis. The aim of this study was to quantify the expression of CKLF1 as well as assess the correlation between CKLF1 and plasma acute-phase markers. Synovium was obtained from 16 osteoarthritis（OA）, 15 rheumatoid arthritis（RA） and 10 ankylosing spondylitis（AS） patients undergoing total joint arthroplasty, with other 11 patients treated for meniscal tears during sport accidents serving as normal controls. Levels of CKLF1 and CCR4 m RNA were detected by q RT-PCR, and the expression of CKLF1 was investigated by immunohistochemistry staining, subsequently analyzed with semiquantitative scores. Plasma acute-phase markers of inflammation were determined by ELISA. CKLF1 was found with a particularly up-regulated expression in synovim from AS and RA patients, and CCR4 m RNA levels increased in RA patients, not in OA or AS patients. Elevated levels of plasma markers of inflammation including CRP, ESR and Ddimer were observed in RA. Further, significantly positive correlations between relative expression levels of CKLF1 and CRP/ESR in RA patients and a positive correlation between CKLF1 and ESR in AS patients were found. There was no detectable correlation between CKLF1 and plasma D-dimer. This study confirms an increased but different level of CKLF1 in RA, OA and AS patients, all significantly higher than that in controls. Additionally, the significant positive correlations between CKLF1 levels and CRP/ESR in RA and between CKLF1 and ESR suggest that CKLF1 might contribute to the inflammation state and clinical symptoms in these rheumatic diseases. Further studies are required to investigate the utility of targeting specific CKLF1 for symptom control or disease modification in RA and AS.展开更多
文摘目的:双膝关节置换术中随机选择一侧置换髌骨,对侧保留髌骨,对比研究髌骨置换与否对术后临床效果的影响。方法:共入选14例双膝骨关节炎患者,28个膝,均为女性,年龄为53~78岁,平均(66.9±7.8)岁,体重指数为(26.3±1.8)kg/m2。随机分组为拟行左侧或右侧髌骨置换和对侧髌骨保留,术后均获随访,随访时间为3~12个月。随访时记录患者手术前后双膝美国膝关节协会评分(American Knee Society score,KSS)、关节活动度(range of motion,ROM)、术后髌骨倾斜角(patellar tilt angle,PTA)、有无术后膝前痛及髌骨弹响、有无术后膝关节并发症等。结果:术后切口均一期愈合,无感染、松动、髌骨骨折等并发症发生。髌骨置换侧KSS评分由术前的(38.9±22.2)分提高至(92.4±6.7)分,术后较术前KSS增加值为(53.5±20.3)分;保留髌骨侧KSS评分由术前的(38.4±20.5)分提高至(92.1±4.2)分,术后较术前KSS增加为(53.7±21.4)分,两组间KSS评分的增加差异无统计学意义(P=0.98)。髌骨置换侧关节活动度由术前的95.4°±13.5°提高至120.4°±8.9°,术后ROM较术前增加为25.0°±14.5°;保留髌骨侧ROM由术前的92.9°±19.1°增加至120.4°±8.4°,术后较术前ROM增加为27.5°±19.4°,两组间ROM的增加差异也无统计学意义(P=0.70)。术后随访时,患者髌骨置换侧出现膝前痛共3膝(占21.4%),而保留髌骨侧膝前痛共出现2膝(占14.3%),两组间膝前痛的发生率比较差异无统计学意义(P=0.62)。术后髌骨置换侧出现髌骨弹响共3膝(占21.4%),保留髌骨侧3膝(占21.4%),组间比较差异无统计学意义。髌骨置换侧术后PTA为2.6°±2.6°,保留髌骨侧为3.6°±2.9°,两者间差异无统计学意义(P=0.36)。结论:全膝关节置换术中,对于髌骨关节面轻中度破坏的骨关节炎患者,髌骨置换较髌骨保留在术后膝前痛、髌骨弹响的发生率、术后关节功能改善及髌股轨迹等方面并无明显优势。
基金supported by National Natural Science Foundation of China(No.81441056 and 81541134)
文摘Chemokine-like factor 1（CKLF1） is a newly cloned chemotactic cytokine with CCR4 being its functional receptor. Recent evidence demonstrates a role of CKLF1 in arthritis. The aim of this study was to quantify the expression of CKLF1 as well as assess the correlation between CKLF1 and plasma acute-phase markers. Synovium was obtained from 16 osteoarthritis（OA）, 15 rheumatoid arthritis（RA） and 10 ankylosing spondylitis（AS） patients undergoing total joint arthroplasty, with other 11 patients treated for meniscal tears during sport accidents serving as normal controls. Levels of CKLF1 and CCR4 m RNA were detected by q RT-PCR, and the expression of CKLF1 was investigated by immunohistochemistry staining, subsequently analyzed with semiquantitative scores. Plasma acute-phase markers of inflammation were determined by ELISA. CKLF1 was found with a particularly up-regulated expression in synovim from AS and RA patients, and CCR4 m RNA levels increased in RA patients, not in OA or AS patients. Elevated levels of plasma markers of inflammation including CRP, ESR and Ddimer were observed in RA. Further, significantly positive correlations between relative expression levels of CKLF1 and CRP/ESR in RA patients and a positive correlation between CKLF1 and ESR in AS patients were found. There was no detectable correlation between CKLF1 and plasma D-dimer. This study confirms an increased but different level of CKLF1 in RA, OA and AS patients, all significantly higher than that in controls. Additionally, the significant positive correlations between CKLF1 levels and CRP/ESR in RA and between CKLF1 and ESR suggest that CKLF1 might contribute to the inflammation state and clinical symptoms in these rheumatic diseases. Further studies are required to investigate the utility of targeting specific CKLF1 for symptom control or disease modification in RA and AS.
